Labrador, Aldrin L.
HRN: 04-15-50 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CEFUROXIME 750MG (VIAL)
03/22/2026
03/28/2026
IV
750mg
Q8
ATP
Checking Initial Appropriateness
03/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/23/2026
03/23/2026
IV
4.5g
Loading Dose
Cap-hr
Checking Initial Appropriateness
03/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/23/2026
03/29/2026
IV
2.25g
Q8h
CAP-HR
Checking Initial Appropriateness